Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 22, Issue 7, pp. 1621-1631
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 11, 2015
- Revision received October 3, 2015
- Accepted October 12, 2015
- Published first November 5, 2015.
Article Versions
- Previous version (November 5, 2015 - 06:38).
- Previous version (January 28, 2016 - 08:02).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Sune Boris Nygård1,
- Ben Vainer2,
- Signe Lykke Nielsen1,
- Fred Bosman3,
- Sabine Tejpar4,
- Arnaud Roth5,
- Mauro Delorenzi6,7,8,
- Nils Brünner1,*, and
- Eva Budinska9
- 1University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark.
- 2Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- 3University of Lausanne, University Institute of Pathology, Lausanne, Switzerland.
- 4Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium.
- 5Oncosurgery Unit, University Hospital of Geneva, Geneva, Switzerland.
- 6SIB Swiss Institute of Bioinformatics, Bioinformatics Core Facility, Lausanne, Switzerland.
- 7University of Lausanne, Ludwig Center for Cancer Research, Lausanne, Switzerland.
- 8Oncology Department, University of Lausanne, Lausanne, Switzerland.
- 9Masaryk University, Institute of Biostatistics and Analyses, Brno, Czech Republic.
- ↵*Corresponding Author:
Nils Brünner, University of Copenhagen, Molecular Disease Biology Section, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, c/o Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark. Phone: +45 3533-3130; Fax: 45-3533-2755, E-mail: nbr{at}sund.ku.dk
April 2016
Volume 22, Issue 7
Volume 22, Issue 7
DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer
Jump to section
Advertisement